Cargando…

Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19

The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards confo...

Descripción completa

Detalles Bibliográficos
Autores principales: Raturi, Manish, Kala, Mansi, Das, Kunal, Kusum, Anuradha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154358/
https://www.ncbi.nlm.nih.gov/pubmed/34054244
http://dx.doi.org/10.1055/s-0041-1727585
_version_ 1783698995603832832
author Raturi, Manish
Kala, Mansi
Das, Kunal
Kusum, Anuradha
author_facet Raturi, Manish
Kala, Mansi
Das, Kunal
Kusum, Anuradha
author_sort Raturi, Manish
collection PubMed
description The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards conformity, with the interim guidelines given by the Food and Drug Administration (FDA) in the United States, United Kingdom’s blood transfusion services, Saudi’s FDA, and the Indian Council for Medical Research, in addition to the European health authorities. It is prudent to address the ethical concerns that merit consideration while harvesting and utilizing CCP as a therapeutic tool in local hospital setting.
format Online
Article
Text
id pubmed-8154358
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-81543582021-05-28 Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 Raturi, Manish Kala, Mansi Das, Kunal Kusum, Anuradha J Lab Physicians The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards conformity, with the interim guidelines given by the Food and Drug Administration (FDA) in the United States, United Kingdom’s blood transfusion services, Saudi’s FDA, and the Indian Council for Medical Research, in addition to the European health authorities. It is prudent to address the ethical concerns that merit consideration while harvesting and utilizing CCP as a therapeutic tool in local hospital setting. Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-03 2021-04-24 /pmc/articles/PMC8154358/ /pubmed/34054244 http://dx.doi.org/10.1055/s-0041-1727585 Text en The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Raturi, Manish
Kala, Mansi
Das, Kunal
Kusum, Anuradha
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
title Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
title_full Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
title_fullStr Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
title_full_unstemmed Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
title_short Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
title_sort reviewing the ethical concerns of the convalescent plasma therapy in covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154358/
https://www.ncbi.nlm.nih.gov/pubmed/34054244
http://dx.doi.org/10.1055/s-0041-1727585
work_keys_str_mv AT raturimanish reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19
AT kalamansi reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19
AT daskunal reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19
AT kusumanuradha reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19